Why the study?
Does fosinopril reduce left ventricular myocardial mass and improve diastolic filling in previously untreated hypertensive patients with LV hypertrophy?
Does fosinopril reduce left ventricular myocardial mass and improve diastolic filling in previously untreated hypertensive patients with LV hypertrophy?
Fosinopril therapy significantly reduces left ventricular mass and normalizes diastolic filling within 6 months in hypertensive patients, as quantifiable by cine MRI.
Answers are grounded in this paper and cite their sources.
Supports fosinopril-associated LV mass regression and diastolic improvement in hypertensive LVH; hypothesis-generating, requiring RCTs before practice change.
Cardiac remodeling in case of hypertension induces hypertrophy of myocytes and elevated collagen content and, subsequently, impaired diastolic filling of the left ventricle. The purpose of this prospective study was to evaluate changes of left ventricular (LV) myocardial mass, as well as diastolic filling properties, in hypertensive patients treated with the ACE inhibitor fosinopril. Sixteen hypertensive patients with echocardiographically documented LV hypertrophy and diastolic dysfunction received fosinopril (10-20 mg daily). Measurements of LV myocardial mass and properties of diastolic filling (peak filling fraction (PFF); peak filling rate (PFR)) were performed prior to medication, as well as after 3 and 6 months of therapy using cine magnetic resonance imaging (MRI). Ten healthy subjects served as a control group. LV myocardial mass (g/m2) decreased continuously within 3-6 months of follow-up by 32% (148 +/- 40 vs. 120 +/- 26 vs. 101 +/- 22 g/m2; P < 0.0001/0.005). The extent of regression correlated to the severity of LV hypertrophy at baseline (r = 0.77; P < 0.004). Early diastolic filling increased significantly within 6 months of therapy (PFF (%): 36 +/- 6 vs. 61 +/- 7, P < 0.0001; PFR (mL/second): 211 +/- 48 vs. 282 +/- 48, P < 0.001). Cine MRI can be used to assess the time course of pharmacological effects on cardiac remodeling in the course of hypertension. ACE inhibitor therapy results in a significant reduction of LV mass within 3 months and is accompanied by a normalization of diastolic filling that is completed after 6 months.
No takes yet. Share an insight, caveat, or question.
Hoffmann et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: